This stock has found its bottom Support at .37 with a decent report we should see a rebound soon . Patience rewarded . Dont forget we are buying future value not present .
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025